Going to the way-back machine to recall how this whole
Going to the way-back machine to recall how this whole combo trial got formed, It was a big win for the FDA to allow us to use safety data from the investigation Mono trial for the pivotal Combo trial. It meant that the Combo trial did not need the much larger population of patients to get to BLA. I don't think the same win can be used to justify the possibility the same safety data could result in a Mono approval without a pivotal trial.
I have not heard any possibility that a mono pivotal trial will not be required, just that the size of the trial could also be small and short because of the Combo trials/approval. I think they refer to it and a label expansion because it is the same use and same drug, so this is an addition to a previous approval.
However, last year when the investigation trial was taking place, there was rumors/discussions that the FDA could convert the investigation into pivotal. It seems like this faded away, and it is likely because the FDA likes a trial that sticks to a protocol and the data supports that protocol. Investigation trials tend to have modifications as data educates how the drug works. It could still happen and the size and detail of the Combo BLA might be an indicator that the FDA is looking at Mono approval, but it would be a surprise if so.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...
Continue Reading
Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...
Continue Reading
GreenCore's Bold Move in FMCG Retail Just when you thought retail couldn't get any more futuristic, here comes GreenCore Solutions Corp. (GSC) shaking up the game with their Agentic Shopping Hub. For the uninitiated, we're not just talking about another e-commerce gimmick—this is a cultural shift. FMCG brands are being told to 'bring their agent' into a realm where AI...
Continue Reading
Challenging Market Yet Strategic Steps Talk about a seesaw of a quarter for JELD-WEN, folks. On the one hand, their net revenues took a dip to $798.5 million, shaving off 1.4% from last year. If you ask why, blame it on a 2% slide in volume/mix. That uptick in price? Well, 1% wasn't enough to save the day. "Our third-quarter results reflect the continued progress we are...
Continue Reading
Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...
Continue Reading
Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...
Continue Reading
Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...
Continue Reading
Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...
Continue Reading
Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...
Continue Reading
Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...
Continue Reading
Top 5 Most Recently Viewed Articles
Swisslog and Medline Enhance Supply Chain with Automation Solution Swisslog, a recognized leader in logistics automation, has embarked on an exciting new project with Medline, a long-standing partner. This collaboration focuses on the implementation of an advanced AutoStore system designed to significantly enhance Medline's order fulfillment capabilities. The New...
Continue Reading
Revolutionizing Healthcare with Wearable Electronic Records In an exciting advancement for digital health, Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) has announced a groundbreaking partnership with MyID, a leader in wearable medical identification technology. This joint venture aims to introduce the first-ever device that integrates a user’s complete, verified...
Continue Reading
Therap Integrates with EVV Aggregator for Enhanced Care Therap Services, a leader in HIPAA-compliant electronic documentation solutions, is taking significant strides forward in support of care providers. By integrating with a new Electronic Visit Verification (EVV) aggregator, Therap aims to enhance the services provided to patients receiving Medicaid personal care and...
Continue Reading
Jabil's stock saw some serious action back in 2024 when BofA Securities hiked its price target from $135 to $150 after a strong Q4 earnings report. They slapped a Buy rating on it, and you know how that goes—traders perk up when the analysts start buzzing about positive outlooks. For fiscal year 2025, Jabil was predicting revenues of around $27 billion and an EPS of...
Continue Reading
AdTech Holding Achieves Recognition for Workplace Excellence AdTech Holding has recently earned the esteemed Great Place To Work® Certification™ for the third consecutive year. This notable achievement reflects the genuine feedback from employees concerning the workplace culture, trust, and the opportunities for professional growth that the company fosters. A...
Continue Reading